Photocure ASA
PHO
Rank in Stocks
#18856
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
Share Price
$4.48
Last synced: 2026-11-09
Market Cap
$120.76M
Change (1 day)
-5.01%
Change (1 year)
-23.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Photocure ASA (PHO)
Category
Healthcare
Operating Margin for Photocure ASA (PHO)
Operating Margin as of November 2026 TTM: 25.97%
According to Photocure ASA's latest financial reports, its current operating margin (TTM) is 25.97%. At the end of 2025 the company had an operating margin of 20.66%.
Operating Margin history for Photocure ASA from 2002 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 25.97% | 25.70% |
| 2025 | 20.66% | 432.47% |
| 2024 | 3.88% | -30.09% |
| 2023 | 5.55% | -144.54% |
| 2022 | -12.46% | -579.23% |
| 2021 | 2.60% | -150.00% |
| 2020 | -5.20% | -134.26% |
| 2019 | 15.18% | -172.70% |
| 2018 | -20.88% | -30.28% |
| 2017 | -29.95% | 171.29% |
| 2016 | -11.04% | -32.35% |
| 2015 | -16.32% | 273.46% |
| 2014 | -4.37% | -94.91% |
| 2013 | -85.92% | 192.94% |
| 2012 | -29.33% | -40.91% |
| 2011 | -49.64% | -1,270.75% |
| 2010 | 4.24% | -102.60% |
| 2009 | -163.03% | 147.35% |
| 2008 | -65.91% | -25.38% |
| 2007 | -88.33% | -337.13% |
| 2006 | 37.25% | -142.29% |
| 2005 | -88.09% | 67.76% |
| 2004 | -52.51% | -46.02% |
| 2003 | -97.28% | -77.60% |
| 2002 | -434.23% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -98.51% |
US
|
|
| -149.01% | -105.74% |
US
|
|
| 25.57% | -99.02% |
AU
|
|
| 31.23% | -98.80% |
BE
|
|
| 29.35% | -98.87% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Photocure ASA's operating margin
What is Photocure ASA's operating margin?
Photocure ASA's operating margin is 25.97%, as of Nov 2026.
What was Photocure ASA's operating margin in 2025?
In 2025, Photocure ASA's operating margin was 20.66%, compared with 3.88% in 2024.
How has Photocure ASA's operating margin changed since 2020?
From 2020 to 2025, Photocure ASA's operating margin was highest in 2025 (20.66%) and lowest in 2022 (-12.46%).
How does Photocure ASA's operating margin compare with similar companies?
Photocure ASA's operating margin (25.97%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.